Evidence map›Paper›PMID 22354974›Full record

ArticleCirculation2012

DNA sequencing: clinical applications of new DNA sequencing technologies.

Frederick E Dewey, Stephen Pan, Matthew T Wheeler, Stephen R Quake, Euan A Ashley

Abstract read
In one paragraph

Article in Circulation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. The fluorescence amplification strategy based on 3D DNA walker and CRISPR/Cas12a for the rapid detection of BRAF V600E.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2022
    Article
  8. Article
  9. Re-focusing on Agnathia-Otocephaly complex.Clinical oral investigations · 2021
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Cost analysis of whole genome sequencing in German clinical practice.The European journal of health economics : HEPAC : health economics in prevention and care · 2017
    Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Frederick E DeweyCenter for Inherited Cardiovascular Disease, Division of Cardiovascular Medicine, Stanford University School of Medicine, Falk CVRB, 300 Pasteur Dr, Stanford, CA 94305, USA.
Stephen Pan
Matthew T Wheeler
Stephen R Quake
Euan A Ashley

Funding

Training in Myocardial Biology at Stanford (TIMBS)T32HL094274 · NHLBI · STANFORD UNIVERSITY · PI Euan A Ashley, Daniel Bernstein · 2010 to 2026
$5.0M
Integrative Cardiovascular Biology of Apelin-APJK08HL083914 · NHLBI · STANFORD UNIVERSITY · PI ASHLEY, EUAN A · 2006 to 2010
$664k
Effect of Cholesterol Anabolism on Network Signaling in Cardiac HypertrophyF32HL097462 · NHLBI · STANFORD UNIVERSITY · PI WHEELER, MATTHEW THOMAS · 2009 to 2009
$57k
NHLBI NIH HHS F32 HL097462NHLBI NIH HHS K08 HL083914NHLBI NIH HHS T32 HL094274NIH HHS DP2 OD004613
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genetic VariationGenome, HumanGenotypeHigh-Throughput Nucleotide SequencingHumansPolymorphism, Single NucleotideQuality ControlSequence Analysis, DNA

Identifiers

PMID22354974
PMCPMC3364518

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.